Xiaobing Duan

Xiaobing Duan

Auto-generated profile, based on publicly available information

Xiaobing Duan

Clinical Laboratory Medicine Department, The Second Affiliated Hospital, Guangzhou Medical University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2023 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
HCHaiwen Chen
Haiwen Chen
XDXiaobing Duan
Xiaobing Duan
XDXiaohong Deng
Xiaohong Deng
YHYingping Huang
Yingping Huang
XZXiang Zhou
Xiang Zhou
TXTong Xiang
Tong Xiang
Nasopharyngeal carcinoma (NPC) is an Epstein–Barr virus (EBV)–associated epithelial malignancy characterized by the presence of prominent infiltration of lymphocytes, including natural killer (NK) cells. Although NK cells can directly target EBV-infected tumor cells without restriction by the MHC, EBV-positive (EBV+) NPC cells often develop resistance mechanisms that allow them to evade immune surveillance by NK cells. Elucidating the mechanisms involved in EBV-induced NK-cell dysfunction will contribute to the design of novel NK cell–based immunotherapies to treat NPC. Herein, we confirmed that the cytotoxic function of NK cells was impaired in EBV+ NPC tissues and found that EBV infection–induced expression of B7-H3 in NPC negatively correlated with NK-cell function. The inhibitory effect of EBV+ tumor expression of B7-H3 on NK-cell function was clarified in vitro and in vivo. Mechanistically, activation of the PI3K/AKT/mTOR signaling pathway via EBV latent membrane protein 1 (LMP1) was responsible for EBV infection–induced upregulation of B7-H3 expression. In an NPC xenograft mouse model with adoptive transfer of primary NK cells, deletion of B7-H3 on tumor cells in combination with anti–PD-L1 treatment restored NK cell–mediated antitumor activity and significantly improved the antitumor efficacy of NK cells. On the basis of our findings, we conclude that EBV infection can inhibit NK cell–mediated antitumor function by inducing upregulation of B7-H3 expression and provide a rationale for NK cell–based immunotherapies in combination of PD-L1 blockade and overcoming the immunosuppression of B7-H3 to treat EBV-associated NPC.

25 September 2024 in EMBO Molecular Medicine
Verified
Journal Article
Open access
XDXiaobing Duan
Xiaobing Duan
JHJiali Hu
Jiali Hu
YZYuncong Zhang
Yuncong Zhang
XZXiaoguang Zhao
Xiaoguang Zhao
MYMingqi Yang
Mingqi Yang
LLLigong Lu
Ligong Lu
Retinoic acid-inducible gene I (RIG-I) is a pattern recognition receptor involved in innate immunity, but its role in adaptive immunity, specifically in the context of CD8 + T-cell antitumour immunity, remains unclear. Here, we demonstrate that RIG-I is upregulated in tumour-infiltrating CD8 + T cells, where it functions as an intracellular checkpoint to negatively regulate CD8 + T-cell function and limit antitumour immunity. Mechanistically, the upregulation of RIG-I in CD8 + T cells is induced by activated T cells, and directly inhibits the AKT/glycolysis signalling pathway. In addition, knocking out RIG-I enhances the efficacy of adoptively transferred T cells against solid tumours, and inhibiting RIG-I enhances the response to PD-1 blockade. Overall, our study identifies RIG-I as an intracellular checkpoint and a potential target for alleviating inhibitory constraints on T cells in cancer immunotherapy, either alone or in combination with an immune checkpoint inhibitor.

7 October 2026 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
MCMingxiao Chen
Mingxiao Chen
QZQingqing Zhi
Qingqing Zhi
MLMiaoshan Luo
Miaoshan Luo
MLMeifang Lin
Meifang Lin
CFCanbo Fan
Canbo Fan
QZQiang Zhou
Qiang Zhou
The global spread of carbapenem-resistant Pseudomonas aeruginosa (CRPA) poses a critical clinical threat, with bla KPC as a key mobile carbapenem resistance gene. Here, we investigated a novel bla KPC-2 genetic element and its transmission in clinical ST2483 isolate PA100 via whole-genome sequencing, molecular, and phenotypic testing, and vesicle analysis. A unique 4,746-bp IS 26 -flanked structure inserted at the chromosomal InaA/pncB2 locus was confirmed, which forms a circular transposition intermediate through IS 26 recombination. PA100 exhibited ~40-fold higher bla KPC-2 copy number and ~25-fold higher mRNA expression vs chromosomal bla KPC-2 strain PA3; meropenem exposure further elevated its transcription by nearly 70-fold, far exceeding controls. PA100 showed an extensively drug-resistant phenotype with high-level carbapenem resistance, while remaining susceptible to ceftazidime-avibactam and cefiderocol. No classical conjugation or transformation was observed, while intact outer membrane vesicles (OMVs) from PA100 carried bla KPC-2 , supporting a non-plasmid, vesicle-associated route for transient delivery of the resistance gene under the tested conditions. The circular transposon remained genetically stable after 10 generations of passaging in PA100; however, stable maintenance in the PAO1 recipient was not detected after passage. In summary, we first report an IS 26 -driven circular bla KPC-2 transposon in ST2483 P. aeruginosa , conferring robust overexpression and stable inheritance in the donor strain, with OMVs potentially facilitating its horizontal spread, although stable maintenance in recipient cells was not demonstrated under the current assay conditions. These data advance understanding of bla KPC dissemination in CRPA and highlight clinical surveillance priorities for rare high-risk sequence types.

6 July 2024
Verified
Dataset
Closed access
XDXiaobing Duan
Xiaobing Duan
BioStudies – one package for all the data supporting a study